Evidence for the benefits of nonantipsychotic pharmacological augmentation in the treatment of depression.
about
The Current Situation on Major Depressive Disorder in China: Research on Mechanisms and Clinical Practice.Modafinil Moderates the Relationship Between Cancer-Related Fatigue and Depression in 541 Patients Receiving Chemotherapy.The discovery and development of vilazodone for the treatment of depression: a novel antidepressant or simply another SSRI?Safety and tolerability of antidepressant co-treatment in acute major depressive disorder: results from a systematic review and exploratory meta-analysis.Reversible Valproate Induced Pisa Syndrome and Parkinsonism in a Neuro-Oncology Patient with Depression and Epilepsy.
P2860
Evidence for the benefits of nonantipsychotic pharmacological augmentation in the treatment of depression.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Evidence for the benefits of n ...... n the treatment of depression.
@en
type
label
Evidence for the benefits of n ...... n the treatment of depression.
@en
prefLabel
Evidence for the benefits of n ...... n the treatment of depression.
@en
P2093
P2860
P1433
P1476
Evidence for the benefits of n ...... n the treatment of depression.
@en
P2093
Changsu Han
Chia-Ming Chang
Soichiro Sato
P2860
P2888
P356
10.1007/S40263-012-0030-1
P478
27 Suppl 1
P577
2013-05-01T00:00:00Z